Skip to content

Sexual activity and prostate cancer: most associations remained uncertain

A review linked more frequent ejaculation with lower prostate cancer odds, while other sexual activity measures showed no statistically significant associations.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Higher ejaculation frequency was associated with lower odds of prostate cancer in this pooled analysis. Intercourse frequency, number of female partners, masturbation frequency and age at first intercourse did not show statistically significant associations. These relationships do not establish that changing sexual behavior prevents cancer, and nonsignificant findings leave uncertainty.

Keep in mind

The abstract omits reference frequencies, exposure categories, underlying study designs and follow-up lengths. This abstract-based account cannot link a specific ejaculation frequency to a defined benefit.

THE NUMBERS, WITH CONTEXT

What researchers found

OR 0.83 (95% confidence interval 0.77 to 0.90)

Prostate cancer odds with higher ejaculation frequency

Pooled odds were 0.83 times those in the reference group, describing relative odds rather than absolute cancer risk. The reference frequency and follow-up timeframe were not reported.

BMC Cancer, 2025 · Original source ↓

Separate measures

The review analyzed ejaculation and masturbation frequency separately, alongside other sexual activity measures. The ejaculation association therefore should not be presented as evidence that masturbation prevents prostate cancer.

What remains uncertain

The confidence interval describes uncertainty around the pooled odds ratio. Even a statistically significant association cannot show that ejaculation itself prevented cancer or reveal an individual's absolute cancer risk.

CHECK THE ORIGINAL

The original publication

Updated dose-response meta-analysis of sexual activity and prostate cancer risk.

Raeisvandi A, Omidi S, Javaheri M et al.
BMC Cancer · 2025

PubMed ID
41345847
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.